Targeted Metabolomics Identifies Glucuronides of Dietary Phytoestrogens as a Major Class of MRP3 Substrates In Vivo

Gastroenterology

Volumn 137, Issue 5, 2009, Pages 1725-1735

  van de Wetering, Koen ^a   Feddema, Wouter ^a   Helms, J Bernd ^b   Brouwers, Jos F ^b   Borst, Piet ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENTERODIOL; ENTEROLACTONE; GLUCURONIDE; MULTIDRUG RESISTANCE PROTEIN 3; PHYTOESTROGEN; SECOISOLARICIRESINOL;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; CONTROLLED STUDY; HORMONE PROTEIN COMPLEX; HORMONE TRANSPORT; HUMAN; HUMAN CELL; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCREENING TEST; URINALYSIS; WILD TYPE;

ANIMALS; GLUCURONIDES; INTESTINAL MUCOSA; METABOLOMICS; MICE; MICE, KNOCKOUT; P-GLYCOPROTEINS; PHYTOESTROGENS; PROTEIN TRANSPORT;

EID: 70350104791     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.06.052     Document Type: Article

References (33)

1. Deeley R.G., Westlake C., and Cole S.P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86 (2006) 849-899
2. Borst P., de Wolf C., and van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 453 (2007) 661-673
3. Kruh G.D., Belinsky M.G., Gallo J.M., et al. Physiological and pharmacological functions of Mrp2, Mrp3, and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer Metastasis Rev 26 (2007) 5-14
4. Belinsky M.G., Dawson P.A., Shchaveleva I., et al. Analysis of the in vivo functions of Mrp3. Mol Pharmacol 68 (2005) 160-168
5. Zelcer N., van de Wetering K., de Waart R., et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol 44 (2006) 768-775
6. Scheffer G.L., Kool M., de Haas M., et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82 (2002) 193-201
7. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40 (2000) 581-616
8. Manautou J.E., de Waart D.R., Kunne C., et al. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology 42 (2005) 1091-1098
9. Zelcer N., van de Wetering K., Hillebrand M., et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci U S A 120 (2005) 7274-7279
10. Qu J., Wang Y., Luo G., et al. Identification and determination of glucuronides and their aglycones in Erigeron breviscapus by liquid chromatography-tandem mass spectrometry. J Chromatogr A 928 (2001) 155-162
11. van de Wetering K., Zelcer N., Kuil A., et al. Multidrug resistance protein 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol Pharmacol 72 (2007) 387-394
12. van de Wetering K., Burkon A., Feddema W., et al. Intestinal BCRP/Bcrp1 and MRP3/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol Pharmacol 75 (2008) 876-885
13. Dixon R.A. Phytoestrogens. Annu Rev Plant Biol 55 (2004) 225-261
14. D'Alessandro T.L., Boersma-Maland B.J., Peterson T.G., et al. Metabolism of phytoestrogen conjugates. Methods Enzymol 400 (2005) 316-342
15. Knust U., Hull W.E., Spiegelhalder B., et al. Analysis of enterolignan glucuronides in serum and urine by HPLC-ESI-MS. Food Chem Toxicol 44 (2006) 1038-1049
16. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5 (2006) 493-506
17. Setchell K.D., Gosselin S.J., Welsh M.B., et al. Dietary estrogens-a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93 (1987) 225-233
18. Adams N.R. Permanent infertility in ewes exposed to plant oestrogens. Aust Vet J 67 (1990) 197-201
19. Whitten P.L., Lewis C., and Naftolin F. A phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats. Biol Reprod 49 (1993) 1117-1121
20. Lewis R.W., Brooks N., Milburn G.M., et al. The effects of the phytoestrogen genistein on the postnatal development of the rat. Toxicol Sci 71 (2003) 74-83
21. Setchell K.D., Brown N.M., Desai P., et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131 (2001) S1362S-S1375S
22. Akita H., Suzuki H., Hirohashi T., et al. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res 19 (2002) 34-41
23. Zeng H., Liu G., Rea P.A., et al. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res 60 (2000) 4779-4784
24. Teng S., and Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 151 (2007) 367-376
25. Jacobs M.N., Nolan G.T., and Hood S.R. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol 209 (2005) 123-133
26. Gregory P.A., Lewinsky R.H., Gardner-Stephen D.A., et al. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199 (2004) 354-363
27. Chen J., Wang S., Jia X., et al. Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos 33 (2005) 1777-1784
28. Kuhnle G., Spencer J.P., Chowrimootoo G., et al. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272 (2000) 212-217
29. Eeckhaut E., Struijs K., Possemiers S., et al. Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. J Agric Food Chem 56 (2008) 4806-4812
30. Maher J.M., Slitt A.L., Cherrington N.J., et al. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos 33 (2005) 947-955
31. Jansen G.H., Arts I.C., Nielen M.W., et al. Uptake and metabolism of enterolactone and enterodiol by human colon epithelial cells. Arch Biochem Biophys 435 (2005) 74-82
32. Axelson M., and Setchell K.D. The excretion of lignans in rats-evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123 (1981) 337-342
33. Borst P., Zelcer N., and van de Wetering K. MRP2 and 3 in health and disease. Cancer Lett 234 (2005) 51-61